Insights On Partnering

1. Clinical Trial Start To Finish …. That Was Easy 2/26/2020

   A sponsor needed to test a new nonsteroidal anti-inflammatory drug (NSAID). Working with an experienced CRO allowed them to line up the 40 best sites in the country for this type of analgesia study and have the best training and tools at each site.

2. How Open Approaches And Interoperability Enable A Better Ecosystem For Clinical Trials 5/19/2020

   As pharma companies and CROs around the world continue to adapt to running trials in this new COVID-19 environment, they are taking this time to reassess the status quo of their technology installations. It’s times like this that you can really delve deep into assessing how “open” or “interoperable” a system really is.

3. Rare Disease: Operationalizing Gene Therapy Trials 10/9/2019

   Even measured against the vast scientific mystery that defines the biotech industry, gene therapy poses extraordinary challenges. This paper explores the history of gene therapy trials, as well as the types of gene therapy vectors and delivery strategies. Also discussed is the regulatory and operational challenges associated with gene therapy trials, including start-up regulations, site selection, recruitment, and retention.

4. A Day In The Life Of A CRA During COVID-19: An Interview With Raquel Telfer 11/18/2020

   Raquel Telfer, Senior Clinical Research Associate at Rho, has been in the clinical research industry for over 10 years. In this blog she speaks candidly about her experience as a CRA, provides examples of how the clinical landscape is evolving for CRAs and patients, and how she finds energy and inspiration during these unsettling times

5. Trends In Clinical Development 4/17/2020

   We asked 329 respondents from sponsor organizations to share their thoughts about a variety of current trends in the clinical development space. We analyzed responses by company size to understand how perspectives of respondents at large sponsors (those spending over $1B annually on R&D) differ from those at non-large organizations. Respondents were provided a list of trend-related statements and asked to rate their level of agreement with each.

6. Bringing Transparency And Collaboration To CRO Oversight 2/24/2020

   Because sponsors often have multiple studies running concurrently with multiple CROs, oversight is complicated, as each CRO has its own method for study startup and for transmitting information back to the sponsor. By transitioning to a solution used by all CROs across the portfolio, oversight improves, and sponsors can build reliable institutional knowledge about CRO performance.

7. Making The Case For Long-Acting Antipsychotic Treatment 2/12/2020

   There is a prevalence of associated symptoms with schizophrenia that antipsychotic drugs don’t treat. Managing these symptoms is essential to improving patient outcomes but remains an elusive goal, even after decades of progress. Read how effectively treating the core symptoms with long-acting drugs represents an effective strategy for addressing associated symptoms of schizophrenia.

8. Digital Recruitment Solutions 2/28/2019

   Whatever your goal may be, online marketing can be integrated into your strategy to help make recruitment a success this fall. Read on to learn how social media and text messaging programs can help support your traditional recruitment campaigns.

9. The Case Of The Elusive Protocol 2/3/2020

   A client required a chart review to evaluate survivability of pediatric patients with a rare metabolic bone disorder. By trying different protocols and overcoming complex issues of informed consent that had to be resolved before the study was successfully completed, they were able to successfully deliver a final clinical study.

10. Establishing Parameters For Success 7/8/2020

    Applying clinical supply management expertise to overcome inventory challenges for a complex, global study. A CRO customer and clinical sponsor both lacked an unblinded supply management role to oversee Interactive Response Technologies platform (IRT) supply strategies and monitor clinical supply inventory levels for a complex global study.